MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.47 -0.23 (-1.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Return on Equity [ROE] (2022 - 2026)

Updated

MoonLake Immunotherapeutics (MLTX) recorded Return on Equity [ROE] of -77.75% in Q2 2026, down 31.26 percentage points from -46.49% a year earlier but up 15.16 percentage points from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Return on Equity [ROE] (2022 - 2026) Analysis & Trends

For FY2025, MoonLake Immunotherapeutics reported Return on Equity [ROE] of -60.78%, down 35.70 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a three-year change of +165.07 percentage points (FY2022 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -25.08% in FY2024 (-9.94 pp), -15.14% in FY2023 (+210.71 pp) and -225.85% in FY2022.
  • Quarterly Return on Equity [ROE] has ranged from -155.58% in Q2 2022 to -8.60% in Q1 2024 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] has declined for eight consecutive quarters, with an average year-over-year change of -34.38 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 135.60 percentage points in Q2 2023, against a drop of 58.77 percentage points in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -92.92% (Q1 2026), -77.33% (Q4 2025) and -65.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 MoonLake Immunotherapeutics 995.75 Mn -673.65 Mn - -77.75%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -77.75%
Mar 31, 2026 -92.92%
Dec 31, 2025 -77.33%
Sep 30, 2025 -65.84%
Jun 30, 2025 -46.49%
Mar 31, 2025 -34.14%
Dec 31, 2024 -25.55%
Sep 30, 2024 -16.14%
Jun 30, 2024 -10.76%
Mar 31, 2024 -8.60%
Dec 31, 2023 -8.79%
Sep 30, 2023 -10.65%
Jun 30, 2023 -19.99%
Mar 31, 2023 -95.16%
Dec 31, 2022 -85.25%
Sep 30, 2022 -70.41%
Jun 30, 2022 -155.58%
API Access

MoonLake Immunotherapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MLTX&period=max&api_key=YOUR_API_KEY